Loading

Cannabis Caucus

  • by Justin Strekal, NORML Political Director November 29, 2017

    Congressman Dana Rohrabacher (R-CA) addresses NORML members in September, 2017

    Today, sixty-six members of Congress representing both Republicans and Democrats sent a letter to Speaker Ryan, Senate Majority Leader McConnell, Leader Pelosi, and Leader Schumer urging them to maintain the federal protections for the 46 states that have implemented some form of medical cannabis programs throughout the country.

    This comes on the same day the Attorney General Jeff Sessions held a press conference to discuss America’s opioid epidemic and made disparaging comments about marijuana.

    “We’re working on that very hard right now,” Sessions said on Wednesday. “We had meetings yesterday and talked about it at some length. It’s my view that the use of marijuana is detrimental and we should not give encouragement in any way to it. And it represents a federal violation which is in the law and is subject to being enforced, and our priorities will have to be focused on all the things and challenges that we face.”

    From Rep. Rohrabacher’s press release:

    Representatives Dana Rohrabacher (CA-48) and Earl Blumenauer (OR-03) spearheaded a letter, signed by 64 other members of the House of Representatives, urging House and Senate leadership to ensure the inclusion of medical marijuana protections in any appropriations bill that funds the government beyond December 8, 2017. The provision, previously known as “Rohrabacher-Farr,” and now “Rohrabacher-Blumenauer,” bars the Department of Justice from using appropriated funds to prosecute individuals who are acting in compliance with their state’s medical marijuana laws. The provision was first signed into law in December 2014 as part of a larger spending package, and has been in force ever since.

    Congressman Earl Blumenauer (D-OR) speaking a NORML Conference

    Reps Rohrabacher and Blumenauer are both co-chairs of the bipartisan Congressional Cannabis Caucus.

    In September, President Donald Trump reached an agreement with Congressional leadership to enact a three-month continuing resolution that maintains present federal spending levels and priorities through December 8, 2017, which included the amendment that was passed in the previous session of Congress.

    Congressional leadership must reauthorize this language as part of the forthcoming budget in order for the provisions to stay in effect. In July, Sen. Patrick Leahy (D-VT) offered identical language before the Senate Appropriations Committee, which approved it. However, House Rules Committee Chair Peter Sessions (R-TX) has refused to allow House members to vote on similar language. The provision will now be considered by House and Senate leadership when the two chambers’ appropriations bills are reconciled.

    It is imperative that the Rohrabacher-Blumenauer amendment remain the law of the land and AG Sessions not be given the green-light to enact a crackdown. Click here to send a message to your federal lawmakers and urge them to speak out about the need to protect the 2 million registered medical marijuana patients throughout the country.

  • by Justin Strekal, NORML Political Director October 12, 2017
    Congressman Earl Blumenauer (D-OR) speaking a NORML Conference

    Congressman Earl Blumenauer (D-OR) speaking at a NORML Conference

    On Wednesday, October 11th, Congressional Cannabis Caucus Co-Chair Earl Blumenauer (D-OR) testified before the House Energy & Commerce Subcommittee on Health on how to deal with the opioid crisis in America.

    In his testimony, the Congressman makes the case for medical cannabis as a safer alternative to highly addictive opioids, especially for our veterans—as well as the need to remove barriers to medical cannabis research.

    It is well documented that medical marijuana access is associated with reduced rates of opioid use and abuse, opioid-related hospitalizations, opioid-related traffic fatalities, and opioid-related overdose deaths.

    Watch the video below and click here to send a message to your elected officials in support of the CARERS Act of 2017 in support of medical marijuana and click here to send a message to the Office of National Drug Control Policy’s Opioid Commission to urge them to include medical marijuana as part of the national strategy to combat the opioid crisis.

  • by Justin Strekal, NORML Political Director October 6, 2017 [caption id="attachment_14163" align="alignright" width="245"]Congressman Earl Blumenauer (D-OR) Congressman Earl Blumenauer (D-OR)[/caption]

    Portland, OR: The Cannabis Fund, a PAC created by Representative Earl Blumenauer to support cannabis-friendly candidates, will be hosting its first annual Gala & Awards on October 6th at the Marriott Waterfront in Portland, OR with NORML founder Keith Stroup as the featured speaker.

    “It is an honor to support Rep. Earl Blumenauer and The Cannabis Fund in 2017. I first met the Congressman in 1973, when he was a freshman state legislator in Oregon who helped pass the nation’s first marijuana decriminalization bill, ending the practice of treating marijuana smokers as criminals. It is exciting to see him continuing to lead the charge to legalize the responsible use of marijuana under federal law, co-founding the Cannabis Caucus in Congress, and author HB 1823, the Marijuana Revenue and Regulation Act,” said Keith Stroup, founder of NORML, “NORML is proud to stand with Rep. Earl Blumenauer in his efforts to end marijuana prohibition and establish a regulated market.”

    Congressman Blumenauer’s Cannabis Profile:

    For more than 40 years, Congressman Earl Blumenauer (OR-03) has fought for the reform of our outdated marijuana laws.

    As an Oregon state legislator, Blumenauer supported the Oregon Decriminalization Bill of 1973, which abolished criminal penalties for possession of small amounts of marijuana.

    Elected to the U.S. House of Representatives in 1996, he has championed several legislative efforts to protect medical marijuana patients, allow the federal government to tax and regulate marijuana, and normalize taxes and banking for marijuana businesses in states where it is legal.

    Blumenauer received the National Organization for the Rationalization of Marijuana Laws Award for Outstanding Public Leadership in 2010. In February 2017, Blumenauer launched the bipartisan Congressional Cannabis Caucus.

  • by Justin Strekal, NORML Political Director September 18, 2017

    First off – a huge thank you to all of those activists and chapter leads from around the country who came to DC to participate in our National Conference and Lobby Day.

    By the numbers:

    –     140+ attendees
    –     21 speakers
    –     5 members of Congress
    –     150+ congressional meetings
    –     1 goal: End marijuana prohibition.

    More to come as we follow up with our attendees and continue to build on the momentum generated (and have our photographer send us the rest of the pictures!).

    Congresswoman Eleanor Holmes Norton (D-DC), Maryland State Senator Richard Madaleno, and aide to Virginia State Senator Dave Marsden receive awards from the DMV NORML Coalition

    Congresswoman Eleanor Holmes Norton (D-DC), Maryland State Senator Richard Madaleno, and aide to Virginia State Senator Dave Marsden receive awards from the DMV NORML Coalition

    Congressman Dana Rohrabacher (R-CA) addresses NORML citizens before they depart to their congressional meetings

    Congressman Dana Rohrabacher (R-CA) addresses NORML citizens before they depart to their congressional meetings

    Senator Cory Booker (D-NJ) met with NORML chapter leaders from around the country to discuss his legislation known as The Marijuana Justice Act

    Senator Cory Booker (D-NJ) met with NORML chapter leaders from around the country to discuss his legislation known as The Marijuana Justice Act

    Some of the feedback from the lobby day we received:

    Mikel Weisser, Executive Director of Arizona NORML in a meeting with Senator Flake’s staffer, reported “She [Katie] is familiar with Endocannabinoid Receptor System. It is one of her policy issue areas. She said she did not know if the Senator was aware of the E.R.S., so I wrote a short note on [the] materials and she said she would show him.”

    In a meeting with Senator Casey’s staffer, Les Stark, head of the Keystone Cannabis Coalition reported “They are open to the issue but do not seem very bold. They don’t want to set too far ahead of the Pennsylvania legislature…we intend to follow-up.”

    Jane Preece, in a meeting with Senator Harris’s staffer, reported “Ms. Hira is smart and is interested in the recent research showing pot is safe and effective.”

    00057959

  • by Justin Strekal, NORML Political Director September 11, 2017

    3410000930_95fc2866fa_zIn a quick deal between President Trump and Congress, a three-month budget continuing resolution will be in effect until December 8, 2017, maintaining current spending levels.

    While this seems mundane (it is), it is important for marijuana policy because it guarantees a temporary extension of the Rohrabacher-Blumenauer protections for lawful medical marijuana programs from Attorney General Jeff Sessions.

    In context, this comes on the heels of the House Rules Committee, led by prohibitionist Representative Pete Sessions (R-TX), blocking multiple amendments related to marijuana from receiving consideration by the full House earlier this week, thus ending their consideration for the 2018 House CJS Appropriates bill.

    Amendments included: ending the federal incentive to revoke drivers licenses from those charged with marijuana offenses; protections for states that have implemented hemp programs; a reduction in funding for the DEA’s cannabis eradication program; expanded access to researchersprotections for banks to provide services to marijuana businesses; allowing the District of Columbia to implement adult-use sales, and expanded protections to the eight states that have outright legalized marijuana.

    Most notably, Chairman Pete Sessions also blocked the amendment offered by Representatives Dana RohrabacherEarl Blumenauer, and other allies in the House This language has been included in budgets since 2014, with language maintains that federal funds cannot be used to prevent states from “implementing their own state laws that authorize the use, distribution, possession or cultivation of medical marijuana.”

    Eariler this year, Senator Patrick Leahy (D-VT) successfully offered and passed the Rohrabacher-Blumenauer amendment in the Senate Appropriations Committee, meaning that the language will be considered in a conference committee regardless of the fact that the full House was denied the opportunity to express it’s support for the 30 states which have legalized medical marijuana and 16 states that have authorized CBD oil access.

    The fight is still to come, and you can send a message to your elected officials about the need to include this in the budget process here by clicking here. 

     

Page 1 of 3123